News Napp launches Neulasta biosimilar in UK Napp’s Pelmeg, a biosimilar of Amgen’s cancer drug Neulasta (pegfilgrastim), has been launched in the UK following
News Amgen faces first Neulasta biosimilar rival as FDA approves ... Amgen’s Neulasta is set to face its first competition in the US after the FDA approved Mylan’s biosimilar version of the blockbuster cancer infection biologic.
News Moderna builds commercial muscle as new launches loom Moderna expands its commercial team, as FDA issues a mostly positive briefing document on its seasonal flu shot, due to face an adcomm tomorrow.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
